“The Cell & Gene Therapy Manufacturing Services Market is experiencing rapid growth, with projections indicating a rise from USD 11.4 billion in 2023 to USD 70.7 billion by 2032. This impressive expansion, representing a Compound Annual Growth Rate (CAGR) of 22.4% from 2024 to 2032, is fueled by a surge in clinical trials, technological advancements, and an increasing demand for scalable manufacturing solutions.”

“The Cell & Gene Therapy Manufacturing Services Market is experiencing rapid growth, with projections indicating a rise from USD 11.4 billion in 2023 to USD 70.7 billion by 2032. This impressive expansion, representing a Compound Annual Growth Rate (CAGR) of 22.4% from 2024 to 2032, is fueled by a surge in clinical trials, technological advancements, and an increasing demand for scalable manufacturing solutions.”